R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 557,840 shares at $16.21 ($9.6M) on 2016-08-16, disclosed to the SEC on 2016-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.21 | 58,600 | $950K | 9.9% |
| 2 | $17.26 | 144,058 | $2.5M | 26.0% |
| 3 | $17.26 | 144,058 | $2.5M | 26.0% |
| 4 | $17.32 | 105,562 | $1.8M | 19.1% |
| 5 | $17.32 | 105,562 | $1.8M | 19.1% |
| Total | $17.17 avg | 557,840 |
| $9.6M |
| 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |